Viewing Study NCT05244057


Ignite Creation Date: 2025-12-24 @ 6:51 PM
Ignite Modification Date: 2025-12-25 @ 4:23 PM
Study NCT ID: NCT05244057
Status: COMPLETED
Last Update Posted: 2024-07-15
First Post: 2022-02-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients
Sponsor: Shanghai HEP Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module